FOX CHASE CANCER CENTER

🇺🇸United States
Ownership
-
Established
1904-01-01
Employees
-
Market Cap
-
Website
http://www.foxchase.org

Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2015-12-17
Last Posted Date
2021-03-09
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
2
Registration Number
NCT02633540
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2015-11-30
Last Posted Date
2024-02-28
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
16
Registration Number
NCT02616965
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

🇺🇸

University of Pennsylvania, Perelman Center, Philadelphia, Pennsylvania, United States

Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients

First Posted Date
2015-11-25
Last Posted Date
2022-03-29
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
29
Registration Number
NCT02614859
Locations
🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

National Cancer Institute, Bethesda, Maryland, United States

Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-11-25
Last Posted Date
2019-11-29
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
26
Registration Number
NCT02614456
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-11-20
Last Posted Date
2021-06-04
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
33
Registration Number
NCT02609230
Locations
🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

Cervical Cancer Screening Intervention Among Korean American Women

First Posted Date
2015-11-03
Last Posted Date
2021-01-26
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
744
Registration Number
NCT02594826
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2015-09-03
Last Posted Date
2022-12-15
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
20
Registration Number
NCT02539459
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

and more 5 locations

Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2015-08-28
Last Posted Date
2022-07-08
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
17
Registration Number
NCT02535247
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Perioperative Risk Study

First Posted Date
2015-05-28
Last Posted Date
2024-03-12
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
1456
Registration Number
NCT02456389
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

A Biobehavioral Model of Diabetes Risk in Chinese Immigrants

Completed
Conditions
First Posted Date
2015-05-20
Last Posted Date
2021-06-04
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
650
Registration Number
NCT02449213
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath